Novamed’s Acquisition of ultilab Industria y Comercio de Productos Farmacéuticos Ltda.

Lefosse and Trench Rossi Watanabe (Baker McKenzie) advised on the deal

Takeda Pharmaceutical Company Limited (TSE: 4502) has signed an agreement with Novamed Fabricação de Produtos Farmacêuticos Ltda., (Novamed), to sell/divest all shares, and all its assets in, Multilab Indústria e Comércio de Produtos Farmacêuticos Ltda. to Novamed.

Novamed, part of the NC Group which owns some of the largest pharmaceutical companies in Brazil, will develop the future business of Multilab by leveraging the synergies of both companies.

Takeda is committed to continuing to help meet the unmet needs of patients in Brazil and to maintaining its ‘best-in-class’ position in its core therapeutic areas, including Gastroenterology and Oncology.

Lefosse advised NC Group with a team including Luiz Octavio Lopes (Picture), Bruno Macorin Carramaschi, Alessandra Cony, Lilian Toscani, Barbara Kobayashi, Felipe Christofi, Juliana Daniel, Luana Torres, Thaise Flores, Vinicius Nogueira, Ana Martinez, Ana Boccalini, Elen Lizas, Luis Hiar, Paulo Peressin, Pablo Dias, Mariana Niquel and Marianna Moura.

Trench Rossi Watanabe (Baker McKenzie) advised Takeda Pharmaceutical Company Limited with Mauricio Pacheco, Lídia Rossi and Caíque Coriolano Harb.

Involved fees earner: Mauricio Pacheco – Trench, Rossi and Watanabe Advogados; Lidia Rossi – Trench, Rossi and Watanabe Advogados; Caique Coriolano Harb – Trench, Rossi and Watanabe Advogados; Luiz Octavio Lopes – Lefosse; Alessandra Cony – Lefosse; Lilian Toscani – Lefosse; Luana Torres – Lefosse; Thaise Flores – Lefosse; Vinicius Nogueira – Lefosse; Ana Luiza Boccalini – Lefosse; Bruno Carramaschi – Lefosse; Ana Martinez – Lefosse; Barbara Kobayashi – Lefosse; Luis Hiar – Lefosse; Felipe Christofi – Lefosse; Juliana Daniel – Lefosse; Elen Lizas – Lefosse; Paulo Peressin – Lefosse; Pablo Dias – Lefosse; Mariana Niquel – Lefosse;

Law Firms: Trench, Rossi and Watanabe Advogados; Lefosse;

Clients: Takeda Pharmaceutical Company Limited; Grupo NC;

Author: Ambrogio Visconti.